Background: CTX-M-type extended-spectrum β-lactamases (ESBLs) are the most prevalent ESBLs in bacterial members of Enterobacteriaceae family including Klebsiella pneumoniae. The global spread of CTX-M-producing K. pneumoniae is a major concern in most countries including Iran. The aim of this meta-analysis was to determine the relative frequency (RF) of bla CTX-M gene among ESBLs-producing K. pneumoniae clinical isolates in Iran and to report an overall prevalence. Methods: A comprehensive literature search of studies published up to July 2016 was carried out. The keywords "Enterobacteriaceae", "Klebsiella pneumoniae", "ESBLs", "CTX-M" and "Iran" were searched in PubMed, Scopus, EBSCO, Google Scholar, Scirus, SID and IranMedex in both English and Persian. Selected articles were published between July 2010 and July 2016 and all of them were in English. STATA SE version 11.0 was used for statistical analysis. Results: Twenty-four articles/abstracts were included in this analysis. Selected studies were performed in Ahvaz, Arak, Ilam, Kashan, Kerman, Mashhad, Shiraz, Tabriz, Tehran, Zabol, and Zahedan. Our pooled evidence showed that the RF of bla CTX-M gene among ESBLs-producing K. pneumoniae clinical isolates varied from 7.7% in Tabriz to 100% in Mashhad, Tehran, and Zahedan, with an overall RF of 56.7%. Conclusion: Our meta-analysis revealed that the RF of CTX-M-type ESBLs-producing K. pneumoniae is diverse in different regions of Iran, and the central and eastern regions had higher prevalence rates compared to western regions.
Introduction
Extended-spectrum β-lactamases (ESBLs) are bacterial enzymes that confer resistance to penicillins, broad-spectrum oxyiminocephalosporins and aztreonam, but suppressed by serine-type β-lactamase inhibitors (e.g. clavulanic acid). ESBLs can be encoded through both chromosome and plasmid genes, and more than ten families have been so far documented to be associated with ESBLs, including CTX-M, SHV, TEM, PER, VEB, BES, GES, TLA, SFO, and OXA. [1] [2] [3] 6-8 K. pneumoniae is one of the major ESBLs-producing bacteria. ESBLsproducing K. pneumoniae is more prevalent in Asia and South America, 9 and has recently been listed as one of the six drug-resistant pathogens for which few potentially effective drugs are available. 10 The worldwide spread of CTX-Mproducing K. pneumoniae is a major concern in most continents such as Asia. [11] [12] [13] Recently, high rate of CTX-M enzymes (as high as 58.5%) among ESBLs-producing K. pneumoniae isolates have been reported in many countries including Brazil, 12 Spain, 14 Korea, 15 etc. To date, several studies have examined the prevalence of CTX-Ms in ESBLs-producing K. pneumoniae clinical isolates in different geographical regions of Iran. Nevertheless, the average rate of CTX-M enzymes among ESBLsproducing K. pneumoniae isolates has not been clearly identified in Iran. Therefore, in this metaanalysis, we reviewed published studies regarding the prevalence of bla CTX-M gene among ESBLsproducing K. pneumoniae clinical isolates in Iran and presented an overall relative frequency (RF).
Materials and Methods

Search Strategy
To identify all related published studies, we searched PubMed, Scopus, EBSCO, Embase, Google Scholar, Scirus and four Persian scientific search engines including IranMedex, IRANDOC, Magiran, and scientific information database (SID) in both English and Persian. The medical subject headings (MESH) and keywords used for the search were "Enterobacteriaceae" and "Klebsiella pneumoniae or K. pneumoniae" and "Extendedspectrum β-lactamases or ESBLs" and "CTX-M" and "Iran". The searched keywords were adapted to the primary language of the database. We also searched the references cited in these articles to find other relevant articles. Selected articles were published between July 2010 and July 2016 and all of them were in English.
Inclusion Criteria
Among obtained articles/abstracts, those with the following features were included in the study: a-Articles that have assessed the prevalence of bla CTX-M gene b-Clinical isolates that were collected from Iranian hospitals c-Clinical isolates that were taken from patients (both inpatients and outpatients) d-Samples that only belonged to the genus Klebsiella, species pneumoniae e-Phenotypic confirmatory ESBL test (either combination disk test or double disc synergy test) which were used to detect ESBL production f-Only ESBLs-producing isolates which were confirmed by phenotypic ESBL test.
Exclusion Criteria
Studies with at least one of the following criteria were excluded from our study: a-Samples that were totally/partially selected from ESBLs collections b-The origin of samples (region or population)
was not clear c-Unclear report of the results
Statistical Analysis
Statistical analysis was executed by the STATA software, version 11.0 (StataCorp, College Station, TX, USA). The overall RF of CTX-M in Iran was pooled by forest plot using the Meta-Analyst software. Heterogeneity among studies was assessed by Cochrane's Q-test and I 2 measurement, which was interpreted as the proportion of total variation contributed among study variants. A P≤0.10 and an I 2 value ≥50% shown significant heterogeneity. A random-effect model was applied in the incidence of significant heterogeneity; if not, a fixed-effect model was executed.
Results
According to heterogeneity test, random model methods were performed for metaanalysis tests (P<0.001). The I 2 >50% indicated the presence of heterogeneity in our pooled analysis.
Out of all papers found by the search of databases, 24 articles matched our inclusion criteria (20 full-text articles and 4 abstracts) selected for our pooled analysis [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (table 1) . A detailed flowchart showing the selection process is presented in figure 1 . These studies were conducted in 10 provinces and 11 cities of Iran. Figure 2 demonstrates the forest plot of the relative frequency of bla CTX-M gene among different studies performed in Iran.
Discussion
In recent years, numerous studies by Iranian researchers have been conducted to identify bla CTX-M gene variants among ESBLs-producing K. pneumoniae clinical isolates. Based on these studies, this review presented a metaanalysis to show the prevalence of bla CTX-M gene among ESBLs-producing K. pneumoniae clinical isolates in Iran. Based on our results, the CTX-M-type ESBLs-producing K. pneumoniae is less frequent in western cities compared to central and eastern cities. The mean prevalence of ESBLs among K. pneumoniae clinical isolates in Iran was 49% that, on average, 56.7% of these isolates (ESBLs-producing isolates) possessed bla CTX-M gene. Lee et al., 11 in their study on K. pneumoniae clinical isolates in 9 Asian countries have shown that ESBLs-production rates differed amongst the studied countries. The percentage of ESBLs-producers was low in Hong Kong and Taiwan (7.7% and 8.3%, respectively), but was high in South Korea, bla CTX-M-3 and bla CTX-M-22 .
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From a regional stand, Iran has a higher mean prevalence of bla CTX-M gene among ESBLs-producing K. pneumoniae clinical isolates compared to reports from neighboring countries including Turkey (30%), 38, 39 Saudi Arabia (35.3%), 40, 41 Iraq (45.2%), 42, 43 and Bahrain (10%) 44 as well as lower mean prevalence compared to Pakistan (96.9%), 45, 46 Kuwait (100%), 47 and United Arab Emirates (64.4%). 48 In a continental perspective, Iran has a lower mean prevalence of bla CTX-M gene among ESBLs-producing K. pneumoniae clinical isolates compared to reports from East Asian countries (78.8%). 11, 49 At the international level, mean prevalence of bla CTX-M gene among ESBLs-producing K. pneumoniae clinical isolates in Iran is higher than USA (26.4%), 50 Russia (34.9%), 51 and South Africa (7.4%) 39 as well as lower than Brazil (62.1%) 12, 52 and Argentina (61.1%) 39 in Latin America and some European countries (84.5%).
9, [53] [54] [55] [56] Our study had some limitations, including lack of published data from certain regions of Iran and the unavailability of some in-press articles that were excluded from our study.
Conclusion
In conclusion, this study showed that the prevalence of CTX- 
